H.C. Wainwright reiterated its buy rating on Ionis Pharmaceuticals following positive data for its hepatitis B treatment. The firm expressed continued confidence in the company's therapeutic advancements.
Analyst ratings from firms like H.C. Wainwright can influence investor sentiment and stock prices. A reiterated 'buy' rating suggests the analyst believes the stock is poised for growth or is undervalued, especially when tied to positive clinical trial data.
Analyst ratings from firms like H.C. Wainwright can influence investor sentiment and stock prices. A reiterated 'buy' rating suggests the analyst believes the stock is poised for growth or is undervalued, especially when tied to positive clinical trial data.
Pick the topics you care about. Get only what matters, on your cadence.
Trading stocks, CFDs, spread betting, futures, and options involves a high level of risk and may not be suitable for all investors. Prices can move rapidly, and losses can occur quickly and exceed your expectations.
